The proteasome deubiquitinase inhibitor b-AP15 enhances DR5 activation-induced apoptosis through stabilizing DR5
Abstract b-AP15 and its derivatives block proteasome deubiquitinase (DUB) activity and have been developed and tested in the clinic as potential cancer therapeutic agents.b-AP15 induces apoptosis in cancer cells, but the underlying mechanisms are largely undefined.The current study focuses on studying the modulatory effects of b-AP15 on death recep